Herpes Simplex Virus (HSV) Vaccines Market Trends Estimates High Demand by 2026

1. Herpes Simplex Virus (HSV) Vaccines Market - Herpes Simplex Virus (HSV) Vaccines Market - Size, Share, Growth, Outlook, and Opportunity Size, Share, Growth, Outlook, and Opportunity Analysis, 2018-2026 Analysis, 2018-2026 Herpes simplex virus (HSV) is known for causing herpes infection. This is majorly found on genitals or mouth and can also be seen on various body parts. There are two types of herpes simplex virus, type 1 (HSV-1) and type 2 (HSV-2), in which HSV-1 is oral herpes causing sores around lips and mouth (fever blisters or cold sores), while HSV-2 is genital herpes, wherein sores are found around genitals and rectum. HSV-1 is very common and extremely contagious infection, and HSV-1 infections occurring around mouth are known as orolabial, oral-labial, or oral –facial herpes. A very few cases of genital herpes (infections occur in genital or anal area) are found in HSV-1. Herpes simplex virus (HSV-2) is most common sexually transmitted virus causing genital herpes (GH) and also highly contagious infection. HSV-2 infection is long lasting and incurable. There is more risk for patients suffering from HSV-2 of getting human immunodeficiency virus (HIV) infection. Probability of reoccurrence of HSV-1 is less frequent than that of HSV-2. Request Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/2845 Factors such as extensive research and development is expected to support global herpes simplex virus (HSV) vaccines market growth over the forecast period. Leading players in the market such as GlaxoSmithKline (GSK), Sanofi SA, and others have HSV vaccines in the development phases. GSK’s vaccine SB208141 completed phase III studies in 2009, which started in 2003. GSK carried out several other clinical trial studies on the same vaccine, considering various different parameters and formulations (with or without monophosphoryl lipid adjuvant [MPL]). Sanofi Pasteur has vaccine HSV529 for HSV-2 is in phase I, whose clinical trial study started in 2015 and completed in 2018. Moreover, Vical, Inc. has VCL-HB01, whose phase I study started in September 2016, and completed in December 2018. Furthermore, Genocea Biosciences, Inc. vaccine GEN-003 is in phase II study where the study started in November 2015 and completed in May 2017. The company also carried out various trial studies with the same vaccine by using an adjuvant Matrix-M2 (It is human respiratory syncytial virus, derived from Quillaja saponins, cholesterol, and phosphatidylcholine).

2. Therefore, robust pipeline is expected to propel global herpes simplex virus (HSV) vaccines market growth over the forecast period. Global Herpes Simplex Virus (HSV) Vaccines Market Regional Analysis Extensive research and development activities in North America are expected to propel herpes simplex virus (HSV) vaccines market growth in the region during the forecast period. Several leading companies are focusing towards research and development of herpes simplex virus (HSV) vaccines for prevention of it. For instance, GEN-003 of Genocea Biosciences, Inc. (based in the U.S.) has shown acceptable safety profile in phase III clinical trials in 2017, so it could be first upcoming vaccine available for HSV in the market boosting global herpes simplex virus (HSV) vaccines market growth. Report includes chapters which deeply display the following deliverable about industry : • Herpes Simplex Virus (HSV) Vaccines Market Research Objective and Assumption • Herpes Simplex Virus (HSV) Vaccines Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Herpes Simplex Virus (HSV) Vaccines Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Herpes Simplex Virus (HSV) Vaccines Market, By Regions • Herpes Simplex Virus (HSV) Vaccines Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Herpes Simplex Virus (HSV) Vaccines Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Herpes Simplex Virus (HSV) Vaccines Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Herpes Simplex Virus (HSV) Vaccines Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Global Herpes Simplex Virus (HSV) Vaccines Market Key Players

3. Some of the major players operating in the global herpes simplex virus (HSV) vaccines market include Sanofi S.A., GlaxoSmithKline Plc., Genocea Biosciences, Inc., Vical, Inc., and others. Inquire Here Before Purchase: https://www.coherentmarketinsights.com/insight/talk-to-analyst/2845 Global Herpes Simplex Virus (HSV) Vaccines market Taxonomy ByVaccine:- GEN-003 VCL-HB01 HSV529 Others • • • • By Indication:- HSV-1 (Oral Herpes) HSV-2 (Genital Herpes) • • By Region North America Latin America Europe Asia Pacific Middle East Africa • • • • • • About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights

4. 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com